A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Rafigrelide | Rafigrelide is a platelet-lowering agent, and also has antithrombotic properties. Uses: Scientific research. Group: Signaling pathways. Alternative Names: 3,3-Dimethylanagrelide. CAS No. 1029711-88-3. Pack Sizes: 5 mg; 10 mg. Product ID: HY-U00383. |  |
| Raf inhibitor 2 | Raf inhibitor 2 is a potent raf kinase (IC 50 <1.0 μM) inhibitor, compound 32, extracted from patent EP1003721B1. Raf inhibitor 2 can be used for cancer research [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 220904-99-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-109574. | |
| Rafivirumab | Rafivirumab (CR57) is an anti-rabies virus monoclonal antibody for the prophylaxis of rabies. Rafivirumab has neutralizing potency against a broad spectrum of RABV variants. Rafivirumab can be used for research of cocktails. Group: Inhibitors. Alternative Names: rafivirumab. CAS No. 944548-37-2. Catalog: ACM944548372. |  |
| Rafoxanide | Rafoxanide is a poent, orally active halogenated salicylaniline agent with antiparasitic activity. Rafoxanide interferes with energy metabolism in trematodes by uncoupling oxidative phosphorylation. Rafoxanide is also found to be a potent inhibitor of the BRAF V600E mutant protein , which is important in colorectal cancer. Rafoxanide can be used for the control of infestation with Hemonchus species or Fasciola species in sheep and cattle as well as Oestrus ovis in sheep. Rafoxanide can also be used for cancer research [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 22662-39-1. Pack Sizes: 10 mM * 1 mL; 500 mg; 1 g; 5 g; 10 g. Product ID: HY-17598. | |
| Rafoxanide | Rafoxanide can be used for the treatment of fasciolasis and fascioliasis in cattle and sheep. Synonyms: Disalan; NSC 355278; BRN 2228187; Ranide; NSC355278; BRN2228187; NSC-355278; BRN-2228187. Grades: >98%. CAS No. 22662-39-1. Molecular formula: C19H11Cl2I2NO3. Mole weight: 626.01. |  |
| Rafoxanide | Rafoxanide is a thyroid hormone receptor. Group: Biochemicals. Alternative Names: N-[3-Chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3,5-diiodobenzamide; 3, 5-Diiodo-3'-chloro-4'- (p-chlorophenoxy) salicylanilide; 3, 5-Diodo-3'-chloro-4'- (p-chlorophenoxy) salicylanilide; 3'-Chloro-4'-(4-chlorophenoxy)-3,5-diiodosalicylanilide; 3'-Chloro-4'-(p-chlorophenoxy)-3,5-diiodosalicylanilide; Disalan; NSC 355278; Ranide. Grades: Highly Purified. CAS No. 22662-39-1. Pack Sizes: 1g. US Biological Life Sciences. |  Worldwide |
| Rafoxanide 13C6 | Rafoxanide 13C6 is a labeled Rafoxanide. Rafoxanide is a salicylanilide used as an antiparasitic agent. Group: Isotope-labeled environmental contaminants. CAS No. 1353867-98-7. Molecular formula: 13C6C13H11Cl2I2NO3. Mole weight: 631.97. Canonical SMILES: O=C ([13C] ([13C]=[13C]1I)=[13C] ([13C] (I)=[13C]1)O)NC (C=C2)=CC (Cl)=C2OC (C=C3)=CC=C3Cl. Catalog: ACM1353867987. | |
| RAGE Antagonist, FPS-ZM1 | A blood-brain-barrier-permeant, non-toxic, tertiary amide compound that acts as a high affinity, potent, multimodal blocker of RAGE (Receptor for Advanced Glycation End products) V domain-mediated ligand binding (Ki = 25, 148, and 230nM, respectively, against Ab40, HMGB1, and S100B, binding to sRAGE). Blocks RAGE-mediated influx of Ab40 and Ab42 into the brain. Also shown to suppress Ab-RAGE induced NF-kB activation and NF-kB-dependent transcription of b-secretase. Daily treatment of APPsw/0 murine AD model (1mg/kg/d via i.p.) is reported to greatly reduce Thioflavin S-positive amyloid plaques in cortex and hippocampus (by 70 to 80%) and restore congnitive performance to the level of non-AD mice.CAS No:945714-67-0. Group: Biochemicals. Grades: Highly Purified. CAS No. 945714-67-0. Pack Sizes: 25mg. US Biological Life Sciences. | Worldwide |
| RAGE antagonist peptide | RAGE antagonist peptide is an advanced glycation end products (RAGE) antagonist. RAGE antagonist peptide prevents RAGE from binding with several of its most important ligands, including HMGB-1, S100P, and S100A4. RAGE antagonist peptide (RAP) possesses anti-tumor and anti-inflammatory activities [1] [2]. Uses: Scientific research. Group: Peptides. CAS No. 1092460-91-7. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P2268. | |
| RAGE antagonist peptide | RAGE antagonist peptide was produced as an inhibitor of the RAGE signaling pathway based on the RAGE-binding domain of high mobility group box-1 (HMGB1). It blocks S100P, S100A4 and HMGB-1 mediated RAGE activation in vitro and in vivo. Synonyms: Ac-Glu-Leu-Lys-Val-Leu-Met-Glu-Lys-Glu-Leu-NH2. CAS No. 1092460-91-7. Molecular formula: C57H101N13O17S. Mole weight: 1272.56. | |
| Rakicidin A | Rakicidin A is originally isolated from Micromonospora sp. R385-2. It has anti-tumor activity in vitro with the IC50 of 40 μg/mL. Molecular formula: C32H54N4O7. Mole weight: 606.79. | |
| Rakicidin B | Rakicidin B is originally isolated from Micromonospora sp. R385-2. It has anti-tumor activity in vitro with the IC50 of 200 μg/mL. Molecular formula: C33H56N4O7. Mole weight: 620.82. | |
| Ralfinamide | Ralfinamide (FCE-26742A) is an orally available Na + blocker derived from α-aminoamide, with function of suppressing pain [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: FCE-26742A. CAS No. 133865-88-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg. Product ID: HY-101437. | |
| Ralfinamide mesylate | Ralfinamide mesylate is a mixed sodium and N-type calcium channel protein inhibitor. Ralfinamide is two fold selective for tetrodotoxin (TTX)-resistant sodium channels compared with TTX-sensitive currents. It displays analgesic effects in animal models of inflammatory and neuropathic pain. Synonyms: (2S) -2-[[[4-[ (2-Fluorophenyl) methoxy]phenyl]methyl]amino]-propanamide methanesulfonate. Grades: ≥99% by HPLC. CAS No. 202825-45-4. Molecular formula: C17H19FN2O2.CH3SO3H. Mole weight: 398.45. | |
| Ralfinamide Mesylate | Ralfinamide Mesylate. Group: Biochemicals. Alternative Names: (2S) -2- [ [ [4- [ (2-Fluorophenyl) methoxy] phenyl] methyl] amino] propanamide Methanesulfonate; (S)-Monomethanesulfonate; (S) -2- [ [4- [ (2-Fluorobenzyl) oxy] benzyl] amino] propanamide Methanesulfonate. Grades: Highly Purified. CAS No. 202825-45-4. Pack Sizes: 25mg. Molecular Formula: C18H23FN2O5S, Molecular Weight: 398.45. US Biological Life Sciences. | Worldwide |
| Ralimetinib | Ralimetinib / LY2228820 is a potent and selective, ATP-competitive inhibitor of p38 MAPK α/β, with IC50s of 5.3 and 3.2 nM, respectively. Group: Fluorinated apis. Alternative Names: LY2228820. CAS No. 862505-00-8. Molecular formula: C24H29FN6. Mole weight: 420.53. Appearance: White to off-white solid powder. Purity: >98%. IUPACName: 5-[2-tert-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)imidazo[4,5-b]pyridin-2-amine. Catalog: OFC862505008. | |
| Ralinepag | Ralinepag is a potent, orally bioavailable and non-prostanoid prostacyclin (IP) receptor agonist, with EC 50 s of 8.5 nM, 530 nM and 850 nM for human and rat IP receptor and human DP1 receptor, respectively. Uses: Scientific research. Group: Signaling pathways. Alternative Names: APD811. CAS No. 1187856-49-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-16751. | |
| Ralinepag | This active molecular is a Epoprostenol receptor agonist which is an investigational drug candidate developed by Arena and intended for the treatment of vasospastic diseases, for an example, Pulmonary Arterial Hypertension. Ralinepag has the potential to mimic prostacyclin which elicits a potent vasodilation and inhibits platelet aggregation when binding to this receptor. In Jan 2015, Phase-II clinical trials in Pulmonary arterial hypertension in USA was on going. In Jul 2015, Phase-II clinical trials in Pulmonary arterial hypertension in Spain was on going. In Jul 2015, Arena initiated enrolment in a phase II extension trial for Pulmonary arterial hypertension in USA, Czech Republic, Hungary, Poland. Uses: Pulmonary arterial hypertension. Synonyms: 2- [ [4- [ [ (4-chlorophenyl) -phenylcarbamoyl] oxymethyl] cyclohexyl] methoxy] acetic acid,APD-811; APD 811; APD811; Ralinepag. Grades: 98%. CAS No. 1187856-49-0. Molecular formula: C23H26ClNO5. Mole weight: 431.91. | |
| Ralmitaront | Ralmitaront Inhibitor. Uses: Scientific use. Product Category: T9183. CAS No. 2133417-13-5. |  |
| Raloxifene | Raloxifene (Keoxifene) is a benzothiophene-derived selective estrogen receptor modulator (SERM). Raloxifene has estrogen-agonistic effects on bone and lipids and estrogen-antagonistic effects on the breast and uterus. Raloxifene is used for breast cancer and osteoporosis research [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Keoxifene; LY156758 free base; LY139481. CAS No. 84449-90-1. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg. Product ID: HY-13738. | |
| Raloxifene-4',6-Diglucuronide Lithium Salt | A metabolite of Raloxifene.Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Grades: > 95%. Molecular formula: C40H41NO16S. 2 Li. Mole weight: 837.71. | |
| Raloxifene 4,6-glucuronide | Raloxifene 4,6-glucuronide. Uses: For analytical and research use. Group: Impurity standards. CAS No. 182507-20-6. Molecular Formula: C40H43NO16S. Mole Weight: 825.84. Catalog: APB182507206. |  |
| Raloxifene 4-β-D-Glucuronide Lithium Salt | | |
| Raloxifene 4-D-glucuronide D4 | Raloxifene 4-D-glucuronide D4 is a formidable metabolite derived from Raloxifene, renowned for its usage in studying osteoporosis within postmenopausal women. Molecular formula: C34H31NO10SD4. Mole weight: 653.73. | |
| Raloxifene-4-D-glucuronide D4 lithium salt | Raloxifene-4-D-glucuronide D4 lithium salt is a notable biomedical compound, aiding in studying postmenopausal osteoporosand breast cancer. Operating as a discerning estrogen receptor modulator, this stable derivative of Raloxifene showcases enhanced solubility and bioavailability conferred by its salt form. Molecular formula: C34H30NO10SD4 Li. Mole weight: 659.66. | |
| Raloxifene-4-D-glucuronide lithium salt | Raloxifene-4-D-glucuronide lithium salt is an esteemed biomedical compound, ingeniously deployed for studying the ravages of osteoporosand curbing the sinister growth of breast cancer. This prodigious innovation is a cleverly modified iteration of raloxifene, an acclaimed selective estrogen receptor modulator (SERM). Molecular formula: C34H34NO10S Li. Mole weight: 655.64. | |
| Raloxifene-4'-D-glucuronide lithium salt | Raloxifene-4'-D-glucuronide lithium salt is a biomedical product used in the research of osteoporosand breast cancer. This compound, containing Raloxifene and lithium, has potential estrogen agonist/antagonist activity, enabling it to selectively modulate estrogen receptors. Its glucuronide form enhances its solubility and bioavailability. Synonyms: Raloxifene 4'-Glucuronide; 182507-22-8; Raloxifene-4-glucuronide; UNII-UZ95WFT3LZ; UZ95WFT3LZ; (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[4-[6-hydroxy-3-[4-(2-piperidin-1-ylethoxy)benzoyl]-1-benzothiophen-2-yl]phenoxy]oxane-2-carboxylic acid; beta-D-Glucopyranosiduronic acid, 4- (6-hydroxy-3- (4- (2- (1-piperidinyl)ethoxy)benzoyl)benzo (b)thien-2-yl)phenyl; beta-D-Glucopyranosiduronic acid, 4-[6-hydroxy-3-[4-[2- (1-piperidinyl) ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl; CHEMBL176790; DTXSID601312492; AKOS040736548; Raloxifene-4'-D-glucuronide lithium salt; HY-135582; CS-0113549; Q27291346; (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(4-(6-hydroxy-3-(4-(2-(piperidin-1-yl)ethoxy)benzoyl)benzo[b]thiophen-2-yl)phenoxy)tetrahydro-2H-pyran-2-carboxylic acid.BETA.-D-GLUCOPYRANOSIDURONIC ACID, 4- (6-HYDROXY-3- (4- (2- (1-PIPERIDINYL)ETHOXY)BENZOYL)BENZO (B)THIEN-2-YL)PHENYL. Molecular formula: C34H35NO10S·xLi. Mole weight: 649.71 (free acid). | |
| Raloxifene-4' -glucuronide | A metabolite of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: 4-[6-Hydroxy-3-[4-2[2- (1-piperindinyl) ethoxy]benzoyl]benzo[b]thien-2-yl]phenyl-b-D-glucopyranosiduronic acid. Grades: > 95%. CAS No. 182507-22-8. Molecular formula: C34H35NO10S. Mole weight: 649.71. | |
| Raloxifene 4-Monomethyl Ether | Raloxifene 4-Monomethyl Ether. Group: Biochemicals. Alternative Names: [6-Hydroxy-2- (4-methoxyphenyl) benzo [b] thien-3-yl] [4- [2- (1-piperidinyl) ethoxy] phenyl] methanone. Grades: Highly Purified. CAS No. 185415-07-0. Pack Sizes: 10mg. Molecular Formula: C29H29NO4S, Molecular Weight: 487.61. US Biological Life Sciences. | Worldwide |
| Raloxifene 6,4-bis-b-D-glucuronide | Raloxifene 6,4-bis-b-D-glucuronide, an enticing biomedical entity, manifests promising potential as a therapeutic agent targeting an array of ailments. Derived from Raloxifene, a selective estrogen receptor modulator (SERM), it serves as a glucuronide metabolite with a primary focus on tackling postmenopausal osteoporosis. Its remarkable aptitude in impeding bone resorption and preserving bone density renders it an efficacious choice in the management of osteoporosis-linked afflictions. Synonyms: (3R,4R,5R,6R)-6-[4-[6-[(2S,3S,4S,5S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-3-[4-(2-piperidin-1-ylethoxy)benzoyl]-1-benzothiophen-2-yl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid; Raloxifene 6,4'-Bis-beta-D-glucuronide; AKOS030241639; Raloxifene 6,4'-Bis- beta -D-glucuronide. CAS No. 182507-20-6. Molecular formula: C40H43NO16S. Mole weight: 825.85. | |
| Raloxifene 6-D-glucuronide | Raloxifene 6-D-glucuronide is a formidable and discriminative estrogen receptor modulator (SERM), aiding in unraveling the intricate labyrinth of Raloxifene's metabolic pathways and elimination mechanisms. Synonyms: 2- (4-Hydroxyphenyl) -3-[4-2[2- (1-piperindinyl) ethoxybenzoyl]benzo[b]thien-6-yl]-b-D-glucopyranosiduronic acid. Molecular formula: C34H35NO10S. Mole weight: 649.71. | |
| Raloxifene 6-D-glucuronide D4 | Raloxifene 6-D-glucuronide D4 is a pharmacological compound for studying osteoporosand breast carcinoma acting as an estrogen receptor modifier. Molecular formula: C34H31NO10SD4. Mole weight: 653.73. | |
| Raloxifene-6-D-glucuronide D4 lithium salt | Raloxifene-6-D-glucuronide D4 lithium salt is a vital pharmaceutical compound extensively employed in the biomedical sector with application revolving around the research of osteoporosis in postmenopausal females. This compound functions as an extraordinary selective estrogen receptor modulator. Molecular formula: C34H30NO10SD4 Li. Mole weight: 659.66. | |
| Raloxifene-6-D-glucuronide lithium salt | Raloxifene-6-D-glucuronide lithium salt is a biomedical compound, used for studying the scourge of osteoporosand hormone receptor-positive breast cancer. It is perched as a lithium salt derivative of Raloxifene-6-D-glucuronide. Molecular formula: C34H34NO10S Li. Mole weight: 655.64. | |
| Raloxifene 6'-glucuronide | Raloxifene 6'-glucuronide. Uses: For analytical and research use. Group: Impurity standards. CAS No. 174264-50-7. Molecular Formula: C34H35NO10S. Mole Weight: 649.71. Catalog: APB174264507. | |
| Raloxifene-6-glucuronide | A metabolite of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: 2- (4-Hydroxyphenyl) -3-[4-[2- (1-piperidinyl) ethoxybenzoyl]benzo[b]thien-6-yl]-β -D-glucopyranosiduronic Acid. Grades: > 95%. CAS No. 174264-50-7. Molecular formula: C34H35NO10S. Mole weight: 649.72. | |
| Raloxifene-6-Glucuronide Lithium Salt | A metabolite of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: 2- (4-Hydroxyphenyl) -3-[4-[2- (1-piperidinyl) ethoxybenzoyl]benzo[b]thien-6-yl]-β -D-glucopyranosiduronic Acid Lithium Salt. Grades: > 95%. Molecular formula: C34H34LiNO10S. Mole weight: 655.64. | |
| Raloxifene 6-Monomethyl Ether | Raloxifene 6-Monomethyl Ether. Group: Biochemicals. Alternative Names: [2- (4-Hydroxyphenyl) -6-methoxybenzo [b] thien-3-yl] [4- [2- (1-piperidinyl) ethoxy] phenyl] methanone. Grades: Highly Purified. CAS No. 178451-13-3. Pack Sizes: 10mg. Molecular Formula: C29H29NO4S, Molecular Weight: 487.61. US Biological Life Sciences. | Worldwide |
| Raloxifene Bismethyl Ether | An intermediate in the synthesis of Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Raloxifene d4 | Heterocyclic Organic Compound. Alternative Names: RALOXIFENE-D4. CAS No. 1185076-44-1. Molecular formula: C28H23D4NO4S. Mole weight: 477.607927112. Appearance: Yellow to Orange Solid. Catalog: ACM1185076441. | |
| Raloxifene-d4 | Deuterated Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4 4-Glucuronide (4- [6-Hydroxy-3- [4- [2- (1-piperidinyl) ethoxy-d4]benzoyl]benzo [b]thien-2-yl]phenyl-ß-D-glucopyranosiduronic acid) | A labeled metabolite of Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Alternative Names: 4- [6-Hydroxy-3- [4- [2- (1-piperidinyl) ethoxy-d4]benzoyl]benzo [b]thien-2-yl]phenyl-ß-D-glucopyranosiduronic acid. Grades: Highly Purified. Pack Sizes: 500ug. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4 6,4-Bis(2,3,4,6-tetra-O-acetyl- β-D-glucuronide Methyl Ester) | An intermediate in the production of labeled Raloxifene metabolites. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4 6,4-Bis- β-D-glucuronide | A labeled metabolite of Raloxifene. Group: Biochemicals. Alternative Names: 2-[4-( β -D-Glucopyranuronosyloxy) phenyl]-3- [4- [2- (1-piperidinyl) ethoxy-d4]benzoyl]benzo [b]thien-6-yl β-D-Glucopyranosiduronic Acid. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4 6-Glucuronide (2-(4-Hydroxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy-d4-benzoyl]benzo[b]thien-6-yl]-ß-D-glucopyranosiduronic acid) | A labeled metabolite of Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Alternative Names: 2-(4-Hydroxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy-d4-benzoyl]benzo[b]thien-6-yl]-ß-D-glucopyranosiduronic acid. Grades: Highly Purified. Pack Sizes: 500ug. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4 bismethyl ether | Heterocyclic Organic Compound. Alternative Names: 6-Methoxy-2-(4-methoxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone-d4; [6-Methoxy-2-(4-methoxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone-d4. CAS No. 1185006-58-9. Molecular formula: C30H27D4NO4S. Mole weight: 505.66. Appearance: Yellow Foam. Purity: 0.96. IUPACName: [6-methoxy-2-(4-methoxyphenyl)-1-benzothiophen-3-yl]-[4-(1,1,2,2-tetradeuterio-2-piperidin-1-ylethoxy)phenyl]methanone. Catalog: ACM1185006589. | |
| Raloxifene-d4 Bismethyl Ether | An intermediate in the synthesis of deuterated Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raloxifene-d4, Hydrochloride | Deuterated Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Raloxifene Dimer Impurity | Raloxifene Dimer Impurity. Uses: For analytical and research use. Group: Impurity standards. CAS No. 618902-12-8. Molecular Formula: C56H52N2O8S2. Mole Weight: 945.16. Catalog: APB618902128. | |
| Raloxifene Dimethoxy Impurity | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Grades: > 95%. Molecular formula: C30H31NO4S. Mole weight: 501.65. | |
| Raloxifene EP Impurity A, N-oxide | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Grades: > 95%. Molecular formula: C42H44N2O8S. Mole weight: 736.89. | |
| Raloxifene EP IMpurity B | Raloxifene EP IMpurity B. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1391054-73-1. Molecular Formula: C28H27NO4S. Mole Weight: 473.59. Catalog: APB1391054731. | |
| Raloxifene EP IMpurity C | Raloxifene EP IMpurity C. Uses: For analytical and research use. Group: Impurity standards. CAS No. 195454-31-0. Molecular Formula: C28H27NO5S. Mole Weight: 489.59. Catalog: APB195454310. | |
| Raloxifene EP IMpurity D | Raloxifene EP IMpurity D. Uses: For analytical and research use. Group: Impurity standards. CAS No. 177744-96-6. Molecular Formula: C21H14O4S. Mole Weight: 362.4. Catalog: APB177744966. | |
| Raloxifene EP IMpurity E | Raloxifene EP IMpurity E. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1700655-64-6. Molecular Formula: C28H27NO4S. Mole Weight: 473.59. Catalog: APB1700655646. | |
| Raloxifene hydrochloride | Raloxifene hydrochloride (Keoxifene hydrochloride) is a second generation selective and orally active estrogen receptor modulator. Raloxifene hydrochloride produces estrogen-agonistic effects on bone and lipid metabolism and estrogen-antagonistic effects on uterine endometrium and breast tissue [1]. Uses: Scientific research. Group: Natural products. Alternative Names: Keoxifene hydrochloride; LY156758; LY139481 hydrochloride. CAS No. 82640-04-8. Pack Sizes: 10 mM * 1 mL; 50 mg; 100 mg. Product ID: HY-13738A. | |
| Raloxifene hydrochloride | Raloxifene is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used for prevention of osteoporosis in postmenopausal women. Uses: Prevention of osteoporosis in postmenopausal women. Synonyms: PD 0332991 isethionate; PD0332991 isethionate; PD-0332991 isethionate; Evista; Raloxifene Hcl; Keoxifene hydrochloride; (6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone hydrochloride. Grades: >98%. CAS No. 82640-04-8. Molecular formula: C28H28ClNO4S. Mole weight: 510.04. | |
| Raloxifene hydrochloride | Raloxifene hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 82640-04-8. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| Raloxifene, Hydrochloride ( [6-Hydroxy-2- (4-hydroxyphenyl) -benzo [b] thien-3-yl] [4- [2- (1-piperidinyl) ethoxy] phenyl] methanone, Keoxifene, LY-139481) | A nonsteroidal estrogen receptor mixed agonist/antagonist. Group: Biochemicals. Alternative Names: [6-Hydroxy-2- (4-hydroxyphenyl) -benzo [b] thien-3-yl] [4- [2- (1-piperidinyl) ethoxy] phenyl] methanone, Keoxifene, LY-139481. Grades: Highly Purified. Pack Sizes: 1g. US Biological Life Sciences. | Worldwide |
| Raloxifene (hydrochloride) (Standard) | Raloxifene (hydrochloride) (Standard) is the analytical standard of Raloxifene (hydrochloride). This product is intended for research and analytical applications. Raloxifene hydrochloride (Keoxifene hydrochloride) is a second generation selective and orally active estrogen receptor modulator. Raloxifene hydrochloride produces estrogen-agonistic effects on bone and lipid metabolism and estrogen-antagonistic effects on uterine endometrium and breast tissue [1]. Uses: Scientific research. Group: Natural products. Alternative Names: Keoxifene (hydrochloride)(Standard); LY156758(Standard); LY139481 (hydrochloride) (Standard). CAS No. 82640-04-8. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-13738AR. | |
| Raloxifene Impurity 1 | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: [6-[ (Methylsulfonyl) oxy]-2-[4-[ (methylsulfonyl) oxy]phenyl]benzo[b]thien-3-yl][4-[2- (1-piperidinyl) ethoxy]phenyl]methanone Hydrochloride;Raloxifene Dimesylate Hydrochloride. Grades: > 95%. CAS No. 84449-85-4. Molecular formula: C30H31NO8S3. HCl. Mole weight: 666.24. | |
| Raloxifene Impurity 1 | Raloxifene Impurity 1. Uses: For analytical and research use. Group: Impurity standards. CAS No. 84449-85-4. Molecular Formula: C30H32ClNO8S3. Mole Weight: 666.21. Catalog: APB84449854. | |
| Raloxifene Impurity 11 | Raloxifene Impurity 11. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1677681-02-5. Molecular Formula: C18H22N2O4S. Mole Weight: 362.44. Catalog: APB1677681025. | |
| Raloxifene Impurity 12 | Raloxifene Impurity 12. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2632-13-5. Molecular Formula: C9H9BrO2. Mole Weight: 229.07. Catalog: APB2632135. | |
| Raloxifene Impurity 13 | Raloxifene Impurity 13. Uses: For analytical and research use. Group: Impurity standards. CAS No. 63675-74-1. Molecular Formula: C16H14O2S. Mole Weight: 270.35. Catalog: APB63675741. | |
| Raloxifene Impurity 15 | Raloxifene Impurity 15. Uses: For analytical and research use. Group: Impurity standards. CAS No. 225648-21-5. Molecular Formula: C15H12O2S. Mole Weight: 256.32. Catalog: APB225648215. | |
| Raloxifene Impurity 18 | Raloxifene Impurity 18. Uses: For analytical and research use. Group: Impurity standards. CAS No. 414861-41-9. Molecular Formula: C14H10O3S. Mole Weight: 258.29. Catalog: APB414861419. | |
| Raloxifene Impurity 19 | Raloxifene Impurity 19. Uses: For analytical and research use. Group: Impurity standards. CAS No. 937666-17-6. Molecular Formula: C14H19NO3. Mole Weight: 249.31. Catalog: APB937666176. | |
| Raloxifene Impurity 2 | An impurity of Raloxifene. Raloxifene is selective estrogen receptor modulator. It can be used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast. Synonyms: 2-(4-Hydroxyphenyl)benzothiophene-6-ol. Grades: > 95%. CAS No. 63676-22-2. Molecular formula: C14H10O2S. Mole weight: 242.3. | |
| Raloxifene Impurity 20 | Raloxifene Impurity 20. Uses: For analytical and research use. Group: Impurity standards. CAS No. 767286-87-3. Molecular Formula: C15H21NO3. Mole Weight: 263.34. Catalog: APB767286873. | |
Our database is helping our users find suppliers everyday.
